NCT01594216 2024-06-12
Ruxolitinib in Estrogen Receptor Positive Breast Cancer
Abramson Cancer Center at Penn Medicine
Phase 2 Completed
Clinical Trials
1 trialsHas results × Estrogen-receptor Positive Invasive Metastatic Breast Cancer × ruxolitinib × Clear all